Genome editing
Programmable genome editors — CRISPR-Cas9, base and prime editors — delivered ex vivo or in vivo in lipid nanoparticles to treat genetic disease: from the first approved CRISPR therapy Casgevy to redosable in-vivo…

How it works
This is a procurement category, not a named manufacturer's product. As a paid service, Bioecon finds suppliers for your task, agrees configuration and specification, and arranges supply; the price is on request. Bioecon may receive a fee from suppliers — this is disclosed and does not affect the portal's grades or lists.
Technology
Genome editing — Evidence, registration route, funding and suppliers are on the technology page.
Programmable genome editors — CRISPR-Cas9, base editors and prime editors — delivered ex vivo or in vivo via lipid nanoparticles to treat genetic disease, from the first approved CRISPR therapy Casgevy to in-vivo redosable CRISPR and single-dose cardiovascular base editing.
Links
- Import and registration route
- CHEM — Minpromtorg (registration) / Rospotrebnadzor (notification of …
- Capabilities
- Testing & analytics